Bill Would Create Chief Pharmaceutical Negotiator at USTR

Posted 8/7/26

The proposal reflects growing congressional concern that foreign drug-pricing policies shift a disproportionate share of pharmaceutical research and development costs to U.S. patients. It would give USTR a dedicated official responsible for identifying and responding to those practices.

This item is available in full to subscribers.

Please log in to continue

Log in